ALECTOR INC. - COMMON STOCK

Alector Reports Fourth Quarter and Full Year 2021 Financial Results

24 Feb 2022 15:05:01 By Nasdaq GlobeNewswire

Alector Announces Appointment of Marc Grasso, M.D., as Chief Financial Officer

07 Feb 2022 07:30:00 By Nasdaq GlobeNewswire

Alector Reports Inducement Grants as permitted by the Nasdaq Listing Rules

03 Jan 2022 15:30:00 By Nasdaq GlobeNewswire

Alector Announces Appointment of Sara Kenkare-Mitra, Ph.D., as President and Head of Research and Development

15 Dec 2021 07:30:00 By Nasdaq GlobeNewswire

Alector Presents Encouraging New AL001 Data from the Symptomatic FTD-GRN Cohort of INFRONT-2 Phase 2 Open-label Clinical Study

12 Nov 2021 12:50:00 By Nasdaq GlobeNewswire

Alector Presents Preclinical Data from AL009 Multi-Siglec Inhibitor Program at the Society for Immunotherapy of Cancer’s 36th Annual Meeting

12 Nov 2021 06:00:03 By Nasdaq GlobeNewswire

Alector to Present at the Stifel 2021 Virtual Healthcare Conference

08 Nov 2021 15:05:01 By Nasdaq GlobeNewswire

Alector Reports Third Quarter 2021 Financial Results

04 Nov 2021 15:05:01 By Nasdaq GlobeNewswire

Alector to Present New Data from Multiple Pipeline Programs at 2021 CTAD Conference and SITC Annual Meeting

03 Nov 2021 15:50:00 By Nasdaq GlobeNewswire

Alector Announces Appointment of Elizabeth A. Garofalo, M.D., to its Board of Directors

28 Sep 2021 07:30:00 By Nasdaq GlobeNewswire

Alector Announces First Participant Dosed in Phase 2 Study Evaluating AL001 in Amyotrophic Lateral Sclerosis (ALS)

09 Sep 2021 07:30:01 By Nasdaq GlobeNewswire

Alector Provides Executive Leadership Update

07 Sep 2021 15:30:00 By Nasdaq GlobeNewswire

Alector to Present at Upcoming Virtual Healthcare Conferences

02 Sep 2021 06:00:02 By Nasdaq GlobeNewswire

Alector Reports Second Quarter 2021 Financial Results

03 Aug 2021 16:09:22 By Nasdaq GlobeNewswire

Alector Presents 12-Month Results from the INFRONT-2 Phase 2 Open-label Clinical Study of AL001 for the Treatment of Symptomatic Frontotemporal Dementia Patients with a Progranulin Mutation

29 Jul 2021 09:10:00 By Nasdaq GlobeNewswire

Alector to Present New Data from Frontotemporal Dementia and Alzheimer’s Disease Programs at the 2021 Alzheimer’s Association International Conference

21 Jul 2021 15:35:14 By Nasdaq GlobeNewswire

Alector and GSK announce global collaboration in immuno-neurology for two clinical stage first-in-class monoclonal antibodies for neurodegenerative diseases

02 Jul 2021 06:38:44 By Nasdaq GlobeNewswire

Alector to Present at Upcoming Virtual Healthcare Conferences

03 Jun 2021 15:05:00 By Nasdaq GlobeNewswire

Alector to Host Virtual Key Opinion Leader Event on Frontotemporal Dementia on June 11, 2021

26 May 2021 15:05:00 By Nasdaq GlobeNewswire

Alector to Present at the BofA Securities 2021 Virtual Health Care Conference

06 May 2021 15:05:01 By Nasdaq GlobeNewswire